The company is focused on developing spinal fusion products for treating degenerative disc disease. The company was able to experience success, despite an 8 percent decline in the number of spinal fusions for DDD performed in the United States.
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.